Title
Use of Hydroquinone and Tretinoin Regulation
Law
Bfad Bureau Circular No. 04, S. 2000
Decision Date
Jun 14, 2000
William D. Torres, Ph.D. directs the implementation of Administrative Order No. 13, S. 1999, regulating the sale of hydroquinone and tretinoin based on concentration levels to ensure public health and safety.

Legal basis: Administrative Order No. 13, s. 1999

  • Administrative Order No. 13, s. 1999 provides classification of preparations containing hydroquinone and/or tretinoin (retinoic acid).
  • Administrative Order No. 13, s. 1999 provides the type of establishment where such preparations may be sold.
  • BFAD Bureau Circular No. 04, s. 2000 mandates strict implementation of the Administrative Order No. 13, s. 1999 provisions by regional officers.

Policy and public-health purpose

  • The regulatory framework is imposed in the interest of public health and safety.
  • The classification and dispensing restrictions are enforced to govern where preparations containing hydroquinone and/or tretinoin (retinoic acid) may be sold.

Core classification for hydroquinone

  • Hydroquinone less than or equal to 2.0% is classified as a Household Remedy, and it may be sold in any establishment if it is placed in a segregated area.
  • Hydroquinone more than 2.0% but less than 3.0% is classified as an Over-the-Counter (OTC) Drug, and it may be sold in drug outlets without need for Doctor’s prescription.
  • Hydroquinone more than 3.0% is classified as a Prescription (Rx) Drug, and it may be sold in drug outlets requiring Doctor’s prescription.

Core classification for tretinoin (retinoic acid)

  • Tretinoin (Retinoic Acid) less than or equal to 0.025% is classified as a Household Remedy, and it may be sold in any establishment if it is placed in a segregated area.
  • Tretinoin (Retinoic Acid) more than 0.025% but less than or equal to 0.05% is classified as an Over-the-Counter (OTC) Drug, and it may be sold in drug outlets without need for Doctor’s prescription.
  • Tretinoin (Retinoic Acid) more than 0.05% is classified as a Prescription (Rx) Drug, and it may be sold in drug outlets requiring Doctor’s prescription.

Classification for combined formulations

  • A combination of Hydroquinone (less than or equal to 2%) and Tretinoin (less than or equal to 0.025%) is classified as a Household Remedy.
  • The combined Hydroquinone + Tretinoin preparation may be sold in any establishment if it is placed in a segregated area.
  • The combined classification is imposed in the interest of public health and safety.

Implementation directives and enforcement responsibility

  • BFAD Bureau Circular No. 04, s. 2000 directs all Regional Food and Drug Regulation Officers to strictly implement the dispensing and outlet rules in Administrative Order No. 13, s. 1999.
  • Regional officers are responsible for ensuring that the classification by concentration and the corresponding type of outlet are followed.
  • The circular emphasizes that efficient and effective discharge of BFAD’s mandate depends on full cooperation and concern from implementing officers.

Analyze Cases Smarter, Faster
Jur helps you analyze cases smarter to comprehend faster, building context before diving into full texts. AI-powered analysis, always verify critical details.